Hyaluronic Acid Modified Nanostructured Lipid Carrier for Targeting Delivery of Kaempferol to NSCLC: Preparation, Optimization, Characterization, and Performance Evaluation In Vitro
Lung cancer seriously threatens the health of human beings, with non-small cell lung cancer (NSCLC) accounting for 80%. Nowadays, the potential position of nano-delivery in treating cancer has been the subject of continuous research. The present research aimed to prepare two molecular weight hyaluro...
Main Authors: | Yufei Ma, Jinli Liu, Xinyu Cui, Jiafu Hou, Fengbo Yu, Jinghua Wang, Xiaoxue Wang, Cong Chen, Lei Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/14/4553 |
Similar Items
-
Development of A Nanostructured Lipid Carrier-Based Drug Delivery Strategy for Apigenin: Experimental Design Based on CCD-RSM and Evaluation against NSCLC In Vitro
by: Xiaoxue Wang, et al.
Published: (2023-09-01) -
Correction: Ma et al. Hyaluronic Acid Modified Nanostructured Lipid Carrier for Targeting Delivery of Kaempferol to NSCLC: Preparation, Optimization, Characterization, and Performance Evaluation In Vitro. <i>Molecules</i> 2022, <i>27</i>, 4553
by: Yufei Ma, et al.
Published: (2024-12-01) -
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
by: Gustavo Henrique Rodrigues da Silva, et al.
Published: (2021-11-01) -
Nanostructured Lipid Carrier Co-Loaded with Docetaxel and Magnetic Nanoparticles: Physicochemical Characterization and In Vitro Evaluation
by: Auni Hamimi Idris, et al.
Published: (2023-04-01) -
Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS
by: Zhu Y, et al.
Published: (2024-07-01)